Skip to content

Impact of Oral Probiotics on Oral Homeostasis

Impact of Oral Probiotics on Oral Homeostasis - a Randomized Double Blind Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04071210
Enrollment
110
Registered
2019-08-28
Start date
2019-10-01
Completion date
2020-03-10
Last updated
2021-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingivitis

Brief summary

Aim: To evaluate the effect of three months use of tablets containing probiotics on the composition of the supragingival plaque microbiota and salivary levels of inflammation-related proteins in oral healthy individuals. Hypothesis: Three months use of tablets containing probiotics will induce quantifiable changes to the composition of the supragingival plaque microbiota and salivary levels of inflammation-related proteins in oral healthy individuals. Perspectives: Data from the present study will be able to reveal the impact of regular use of probiotics on oral homeostasis in oral healthy individuals. Specifically, simultaneous registration of clinical, microbial and inflammatory characteristics will provide comprehensive information on the potential beneficial effect of regular use of oral probiotics on maintenance of oral homeostasis. Thus, data from the present study will provide a scientific platform, which dentist and dental hygienist can utilize when deciding if oral healthy individuals may benefit from using oral probiotics as a supplement to regular oral hygiene.

Detailed description

Oral health is built upon a symbiotic relationship between the resident oral microbiota and the immune system of the host. Therefore, structural or functional changes to either the microbiota or the immune system may result in dysbiosis, which in turn can lead to oral diseases such as gingivitis, periodontitis and dental caries. The composition of the resident oral microbiota in oral health is shaped by ecological properties found at various sites of the oral cavity, which is why major site-specific variations are observed. Interestingly, the composition of the oral microbiota is individualized and relatively time stable as long as oral homeostasis is maintained. However, structure and function of the oral microbiota can be altered by internal and external perturbations. For example, it has previously demonstrated that oral hygiene discontinuation induces structural changes to the supragingival plaque microbiota, whereas non-surgical periodontal treatment has deep impact on the composition of the subgingival plaque microbiota. Interestingly, a recent study demonstrated that the composition of the resident oral microbiota may also be influenced by external perturbations. Specifically, daily use of ZendiumTM toothpaste for 12 weeks was reported to induce significant changes to the supragingival plaque microbiota in oral healthy individuals with an increase in health-associated bacterial species. Probiotics is the term used when a harmless effector strain is implanted in the host's microbiota to maintain or restore a natural microbiome by interference and/or inhibition of other microorganisms, and especially pathogens. In a recent study, it was demonstrated an effect of using tablets containing a mix of Lactobacillus rhamnosus PB01, DSM 14869 and Lactobacillus curvatus EB10, DSM 32307 on gingival inflammation. Specifically, daily use of this probiotic candidate for four weeks resulted in significant reduction in clinical parameters such as bleeding on probing (BOP) and amount of gingival crevicular fluid (GCF). However, at present it is not known if daily use of a probiotic tablet containing a mix of L. rhamnosus PB01, DSM 14869 and L. curvatus EB10, DSM 32307 is able to induce shifts to the composition of the oral microbiota, or cause a decrease in salivary levels of inflammation-related proteins such as neutrophil gelatinase-associated lipocalin (NGAL) and transferrin, which is the purpose of the present study.

Interventions

DIETARY_SUPPLEMENTProbiotic tablet

Probiotic tablet twice a day for 12 weeks

DIETARY_SUPPLEMENTPlacebo tablet

Placebo tablet twice a day for 12 weeks

Sponsors

University of Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

PI are the only one aware of participant status.

Intervention model description

Randomized double blind clinical trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* age \> 18 yrs.

Exclusion criteria

* gingivitis * periodontitis * dental caries * systemic disease * current medication * antibiotic treatment within the latest 3 months.

Design outcomes

Primary

MeasureTime frameDescription
Change in bacterial diversity of supragingival plaque microbiota from baseline to week 12Baseline alpha-diversity vs. alpha-diversity at week 12Alpha-diversity measured by shannon index

Secondary

MeasureTime frameDescription
Change in salivary levels of neutrophil gelatinase-associated lipocalin (NGAL) from baseline to week 12Baseline levels vs. leves at week 12.Mean levels of NGAL (mg/mL) measured by ELISA
Change in Salivary levels of transferrin from baseline to week 12Baseline levels vs. leves at week 12.Mean levels of transferrin (mg/mL) measured by ELISA

Other

MeasureTime frameDescription
Change in plaque index (PI) from baseline to week 12Baseline recordings vs. recordings at week 12.Mean levels of PI (% of sites with positive recordings)
Change in gingival inflammation index (GI) from baseline to week 12Baseline recordings vs. recordings at week 12.Mean levels of GI (% of sites with positive recordings)
Change in bleeding index (BI) from baseline to week 12Baseline recordings vs. recordings at week 12.Mean levels of BI (% of sites with positive recordings)

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026